ArticleBMJ global health2021
Use of social impact bonds in financing health systems responses to non-communicable diseases: scoping review.
Article in BMJ global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Broadening sources of finance for health promotion and disease prevention: Smart capacitating investment.The European journal of health economics : HEPAC : health economics in prevention and care · 2026Article
- Payment mechanisms to improve prevention spending in health care settings: A policy-focused evidence brief.Public health in practice (Oxford, England) · 2026Article
- Investment in preventive health needs to be seen as a driver of economic development.PLoS medicine · 2026Article
- Social impact bonds: opportunities for funding health promotion and disease prevention.BMC public health · 2026Article
- The feasibility of social impact bonds in financing tertiary health care quality: qualitative stakeholders' perspectives in Kenya.Health economics review · 2026Article
- The maternal and child mortality in the Middle East and North Africa between 2000 and 2020: the role of health financing.Global health research and policy · 2025Article
- Article
- In with the good, out with the bad - Investment standards for external funding of health?Health policy OPEN · 2023Article
- Article
- Quantitative revenue estimates and qualitative assessments of innovative fundraising sources for treating rare diseases in Colombia.Journal of market access & health policy · 2023Article
- 'Implementability' matters: using implementation research steps to guide and support non-communicable disease national planning in low-income and middle-income countries.BMJ global health · 2022Review
- Evidence-Based Analysis of Social Impact Bonds for Homelessness: A Scoping Review.Frontiers in psychology · 2022Article
- Digital Health Approaches for Improved Population Health Outcomes: Time for a Disease Vulnerability Matrix for Individuals and Communities?Frontiers in digital health · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is an interest to understand how social impact bonds (SIBs), a type of innovative financing instrument used in impact investment, can be used to finance the prevention of non-communicable diseases (NCDs). This is the first scoping review that explores the evidence of SIBs for NCDs and their key characteristics and performance. The review used both published and grey literature from eight databases (MEDLINE, NCBI, Elsevier, Cochrane Library, Google, Google Scholar, WHO publications and OECD iLibrary). A total of 83 studies and articles were eligible for inclusion, identifying 11 SIBs implemented in eight countries. The shared characteristics of the SIBs used for NCDs were impact investment companies as investors, local governments as outcome payers, not-for-profit service providers and an average US$2 015 456 private initial investment. The review revealed a lack of empirical evidence on SIBs for NCDs. Conflict of interest and lack of public disclosure were common issues in both the published and grey literature on SIBs. Furthermore, only three SIBs implemented for financing NCDs were meeting all their target outcomes. The common characteristics of the SIBs meeting their target outcomes were evidence-based interventions, multiple service providers and an intermediated structure. Overall, there is a need for more high-quality studies, particularly economic evaluations and qualitative studies on the benefits to target populations, and greater transparency from the private sector, in order to ensure improved SIBs for preventing NCDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.